• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性氧代谢物的血清衍生物与慢性阻塞性肺疾病的严重程度相关,并受 p53 基因多态性影响。

Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a p53 Gene Polymorphism.

机构信息

Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa, Japan.

出版信息

Int J Chron Obstruct Pulmon Dis. 2022 Jul 13;17:1589-1600. doi: 10.2147/COPD.S366792. eCollection 2022.

DOI:10.2147/COPD.S366792
PMID:35854898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9289177/
Abstract

PURPOSE

Oxidative stress is known to activate tumor suppressor p53, which inhibits cell cycle progression and induces apoptosis. Levels of p53 in lung tissues from patients with chronic obstructive pulmonary disease (COPD) are increased compared with levels in nonsmokers or smokers without emphysema. A polymorphism in p53 codon 72 (rs1042522) is associated with emphysematous changes in patients with COPD. However, whether oxidative stress in the serum is associated with the p53 polymorphism and disease severity in COPD patients is unclear.

PATIENTS AND METHODS

A total of 251 patients with a history of smoking more than 10 pack-years were enrolled in this study, and serum levels of derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant potential (BAP), and d-ROMs/BAP ratio (oxidative stress index; OSI) were measured. The percent low-attenuation area (LAA%) and cross-sectional area of the erector spinae muscles (ESM) at the Th level were calculated from chest high-resolution computed tomography images. p53 codon 72 C/G genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism analysis.

RESULTS

In patients carrying the p53 GG genotype, LAA% was significantly higher than in those carrying the CC genotype. d-ROM levels and OSI were associated with COPD severity and correlated with airflow limitation and markers of muscle atrophy (ESM and creatinine/cystatin C ratio). Associations between markers of oxidative stress and COPD severity were observed primarily in patients carrying the p53 codon 72 GG genotype.

CONCLUSION

Susceptibility to pulmonary emphysema and responses to oxidative stress may be affected by the p53 gene polymorphism.

摘要

目的

氧化应激已知可激活肿瘤抑制因子 p53,p53 可抑制细胞周期进程并诱导细胞凋亡。与不吸烟者或非肺气肿吸烟者相比,慢性阻塞性肺疾病(COPD)患者的肺组织中 p53 水平升高。p53 密码子 72 (rs1042522)的多态性与 COPD 患者的肺气肿变化有关。然而,血清中的氧化应激是否与 COPD 患者的 p53 多态性和疾病严重程度有关尚不清楚。

方法

共纳入 251 例吸烟超过 10 包年的患者,测量血清中活性氧代谢物衍生物(d-ROMs)、生物抗氧化潜能(BAP)和 d-ROMs/BAP 比值(氧化应激指数;OSI)水平。通过胸部高分辨率计算机断层扫描图像计算低衰减区百分比(LAA%)和 Th 水平竖脊肌的横截面积(ESM)。使用聚合酶链反应-限制性片段长度多态性分析进行 p53 密码子 72 C/G 基因分型。

结果

携带 p53 GG 基因型的患者的 LAA%明显高于携带 CC 基因型的患者。d-ROM 水平和 OSI 与 COPD 严重程度相关,与气流受限和肌肉萎缩标志物(ESM 和肌酐/胱抑素 C 比值)相关。在携带 p53 密码子 72 GG 基因型的患者中,观察到氧化应激标志物与 COPD 严重程度之间的相关性。

结论

对肺气肿的易感性和对氧化应激的反应可能受 p53 基因多态性的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/ce64c2555878/COPD-17-1589-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/d5962110e53d/COPD-17-1589-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/4e0363fcd8a7/COPD-17-1589-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/8356062fd1cb/COPD-17-1589-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/08e34b8d5c18/COPD-17-1589-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/3304ce631acb/COPD-17-1589-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/7e38e45aba9d/COPD-17-1589-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/ce64c2555878/COPD-17-1589-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/d5962110e53d/COPD-17-1589-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/4e0363fcd8a7/COPD-17-1589-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/8356062fd1cb/COPD-17-1589-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/08e34b8d5c18/COPD-17-1589-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/3304ce631acb/COPD-17-1589-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/7e38e45aba9d/COPD-17-1589-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694c/9289177/ce64c2555878/COPD-17-1589-g0007.jpg

相似文献

1
Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a p53 Gene Polymorphism.活性氧代谢物的血清衍生物与慢性阻塞性肺疾病的严重程度相关,并受 p53 基因多态性影响。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 13;17:1589-1600. doi: 10.2147/COPD.S366792. eCollection 2022.
2
Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.血清肌酐/胱抑素 C 比值与慢性阻塞性肺疾病患者竖脊肌横截面积和肺功能的关系。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 24;16:3513-3524. doi: 10.2147/COPD.S339243. eCollection 2021.
3
Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.慢性阻塞性肺疾病患者竖脊肌的定量评估。一种新的基于胸部 CT 的预后指标。
Ann Am Thorac Soc. 2016 Mar;13(3):334-41. doi: 10.1513/AnnalsATS.201507-446OC.
4
Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.基质金属蛋白酶-9启动子多态性与上叶优势型肺气肿相关。
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1378-82. doi: 10.1164/rccm.200506-953OC. Epub 2005 Aug 26.
5
p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD.p53 信号通路多态性与 COPD 患者肺气肿变化相关。
Chest. 2017 Jul;152(1):58-69. doi: 10.1016/j.chest.2017.03.012. Epub 2017 Mar 15.
6
A Polymorphism rs6726395 in Nrf2 Contributes to the Development of Emphysema-Associated Age in Smokers Without COPD.Nrf2 基因 rs6726395 多态性与非 COPD 吸烟者肺气肿发病年龄相关。
Lung. 2019 Oct;197(5):559-564. doi: 10.1007/s00408-019-00251-2. Epub 2019 Jul 11.
7
Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography.使用筛查性计算机断层扫描术识别肺气肿或气道疾病等隐匿性实质疾病。
COPD. 2010 Apr;7(2):117-25. doi: 10.3109/15412551003631717.
8
Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.随着年龄的增长,血清转化生长因子-β1 浓度降低与慢性阻塞性肺疾病肺气肿的严重程度相关。
Geriatr Gerontol Int. 2013 Oct;13(4):1069-75. doi: 10.1111/ggi.12031. Epub 2013 Feb 26.
9
Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.全基因组关联研究鉴定 BICD1 是肺气肿的易感性基因。
Am J Respir Crit Care Med. 2011 Jan 1;183(1):43-9. doi: 10.1164/rccm.201004-0541OC. Epub 2010 Aug 13.
10
Quantitative Computed Tomography Assessment of Pectoralis and Erector Spinae Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease Referred for Lung Volume Reduction.定量计算机断层扫描评估慢性阻塞性肺疾病患者行肺减容术治疗的胸肌和竖脊肌面积与疾病严重程度。
COPD. 2021 Apr;18(2):191-200. doi: 10.1080/15412555.2021.1897560. Epub 2021 Mar 19.

引用本文的文献

1
Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective Study.血清衍生物反应性氧代谢产物水平作为支气管哮喘、慢性阻塞性肺疾病或哮喘-慢性阻塞性肺疾病重叠患者临床状况的标志物:一项前瞻性研究。
J Clin Med. 2024 Oct 9;13(19):6022. doi: 10.3390/jcm13196022.
2
Knockdown of GNL3L Alleviates the Progression of COPD Through Inhibiting the ATM/p53 Pathway.GNL3L 敲低通过抑制 ATM/p53 通路缓解 COPD 的进展。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 18;18:2645-2659. doi: 10.2147/COPD.S424431. eCollection 2023.
3
A titratable murine model of progressive emphysema using tracheal porcine pancreatic elastase.

本文引用的文献

1
Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.血清肌酐/胱抑素 C 比值与慢性阻塞性肺疾病患者竖脊肌横截面积和肺功能的关系。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 24;16:3513-3524. doi: 10.2147/COPD.S339243. eCollection 2021.
2
Reactive Oxygen Species and Antioxidative Defense in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的活性氧与抗氧化防御
Antioxidants (Basel). 2021 Sep 28;10(10):1537. doi: 10.3390/antiox10101537.
3
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
采用气管内猪胰弹性蛋白酶制作可滴定的进展性肺气肿鼠模型。
Sci Rep. 2023 Sep 14;13(1):15259. doi: 10.1038/s41598-023-41527-1.
血清肌酐/胱抑素 C 比值作为慢性阻塞性肺疾病患者肌少症的替代标志物。
Clin Nutr. 2021 Mar;40(3):1274-1280. doi: 10.1016/j.clnu.2020.08.010. Epub 2020 Aug 19.
4
NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD.与 COPD 肌少症相关的新型抗氧化和氧化生物标志物。
Heart Lung. 2021 Jan-Feb;50(1):184-191. doi: 10.1016/j.hrtlng.2020.06.001. Epub 2020 Jun 14.
5
Oxidative stress-based therapeutics in COPD.COPD 的基于氧化应激的治疗策略。
Redox Biol. 2020 Jun;33:101544. doi: 10.1016/j.redox.2020.101544. Epub 2020 Apr 20.
6
The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue.COPD 中丙烯醛与氧化应激的关系:在系统血浆和局部肺组织中。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 12;14:1527-1537. doi: 10.2147/COPD.S208633. eCollection 2019.
7
Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.比较 COPD 患者和非 COPD 患者吸烟者的氧化应激/抗氧化平衡。
Heart Lung. 2019 Nov-Dec;48(6):566-569. doi: 10.1016/j.hrtlng.2019.07.005. Epub 2019 Jul 29.
8
Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease.线粒体、端粒和细胞衰老:对肺衰老和疾病的影响。
Pharmacol Ther. 2018 Mar;183:34-49. doi: 10.1016/j.pharmthera.2017.10.005. Epub 2017 Oct 4.
9
ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema.ADRB2 基因多态性和肺气肿异质性可调节肺气肿患者的支气管扩张剂反应。
Pulm Pharmacol Ther. 2018 Feb;48:80-87. doi: 10.1016/j.pupt.2017.09.004. Epub 2017 Sep 28.
10
Study of oxidative stress biomarkers in chronic obstructive pulmonary disease and their correlation with disease severity in north Indian population cohort.印度北部人群队列中慢性阻塞性肺疾病氧化应激生物标志物的研究及其与疾病严重程度的相关性
Lung India. 2017 Jul-Aug;34(4):324-329. doi: 10.4103/lungindia.lungindia_205_16.